clinical trial · NCT00836004

Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditions

Teva Pharmaceuticals USA·phase1·completed·n = 24

HealthyClindamycin 300 mg capsuleCleocin HCl 300 mg capsules

brief summary

The objective of this study is to compare the rate and extent of absorption of clindamycin 300 mg capsules (test) versus Cleocin HCl (reference, administered as 1 x 300 mg capsule under fed conditions.

started

Nov 1, 2003

primary completion

Nov 1, 2003

completion

Nov 1, 2003

last updated

Aug 19, 2024

detailed description

Criteria for Evaluation: FDA Bioequivalence Criteria

Statistical Methods: FDA bioequivalence statistical methods

official title

Randomized, 2-Way Crossover, Bioequivalence Study of Clindamycin 300 mg Capsules and Cleocin Hcl Administered as 1 x 300 mg Capsule in Healthy Subjects Under Fed Conditions

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol